Literature DB >> 31377949

Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families.

Bernardo Machado Dias Domingues1, Fábio A Nascimento2, Alex Tiburtino Meira1, Adriana Moro3, Salmo Raskin4, Tetsuo Ashizawa5, Hélio Afonso Ghizoni Teive6.   

Abstract

Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant disorder in which patients have a slowly progressive cerebellar ataxia, with dysarthria, dysphagia, and epilepsy. The aims of this study were to characterize the phenotypic expression of SCA10 and to examine its genotype-phenotype relationships. Ninety-one Brazilian patients with SCA10 from 16 families were selected. Clinical and epidemiological data were assessed by a standardized protocol, and severity of disease was measured by the Scale for the Assessment and Rating of Ataxia (SARA). The mean age of onset of symptoms was 34.8 ± 9.4 years. Sixty-two (68.2%) patients presented exclusively with pure cerebellar ataxia. Only 6 (6.6%) of the patients presented with epilepsy. Patients with epilepsy had a mean age of onset of symptoms lower than that of patients without epilepsy (23.5 ± 15.5 years vs 35.4 ± 8.7 years, p = 0.021, respectively). All cases of intention tremor were in women from one family. This family also had the lowest mean age of onset of symptoms, and a higher percentage of SCA10 cases in women. There was a positive correlation between duration of disease and severity of ataxia (rho = 0.272, p = 0.016), as quantified by SARA. We did not find a statistically significant correlation between age of onset of symptoms and expansion size (r = - 0.163, p = 0.185). The most common clinical presentation of SCA10 was pure cerebellar ataxia. Our data suggest that patients with epilepsy may have a lower age of onset of symptoms than those who do not have epilepsy. These findings and the description of a family with intention tremor in women with earlier onset of symptoms draw further attention to the phenotypic variability of SCA10.

Entities:  

Keywords:  Autosomal dominant cerebellar ataxia; Epilepsy; Intention tremor; SCA10; Seizure; Spinocerebellar ataxia

Mesh:

Substances:

Year:  2019        PMID: 31377949     DOI: 10.1007/s12311-019-01064-y

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  26 in total

1.  Ethnic origin and extrapyramidal signs in an Argentinean spinocerebellar ataxia type 10 family.

Authors:  E M Gatto; R Gao; M C White; M C Uribe Roca; J L Etcheverry; G Persi; J J Poderoso; T Ashizawa
Journal:  Neurology       Date:  2007-07-10       Impact factor: 9.910

2.  Spinocerebellar ataxia type 10: Frequency of epilepsy in a large sample of Brazilian patients.

Authors:  Hélio A G Teive; Renato P Munhoz; Salmo Raskin; Walter O Arruda; Luciano de Paola; Lineu C Werneck; Tetsuo Ashizawa
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

3.  Scale for the assessment and rating of ataxia: development of a new clinical scale.

Authors:  T Schmitz-Hübsch; S Tezenas du Montcel; L Baliko; J Berciano; S Boesch; C Depondt; P Giunti; C Globas; J Infante; J-S Kang; B Kremer; C Mariotti; B Melegh; M Pandolfo; M Rakowicz; P Ribai; R Rola; L Schöls; S Szymanski; B P van de Warrenburg; A Dürr; T Klockgether; Roberto Fancellu
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

4.  Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10.

Authors:  A Rasmussen; T Matsuura; L Ruano; P Yescas; A Ochoa; T Ashizawa; E Alonso
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

5.  Clinical phenotype of Brazilian families with spinocerebellar ataxia 10.

Authors:  H A G Teive; B B Roa; S Raskin; P Fang; W O Arruda; Y Correa Neto; R Gao; L C Werneck; T Ashizawa
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

6.  Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA).

Authors:  Pedro Braga-Neto; Clecio Godeiro-Junior; Lívia Almeida Dutra; José Luiz Pedroso; Orlando Graziani Povoas Barsottini
Journal:  Arq Neuropsiquiatr       Date:  2010-04       Impact factor: 1.420

7.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10.

Authors:  T Matsuura; T Yamagata; D L Burgess; A Rasmussen; R P Grewal; K Watase; M Khajavi; A E McCall; C F Davis; L Zu; M Achari; S M Pulst; E Alonso; J L Noebels; D L Nelson; H Y Zoghbi; T Ashizawa
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

8.  Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10.

Authors:  Raji P Grewal; Madhureeta Achari; Tohru Matsuura; Alberto Durazo; Emilio Tayag; Lan Zu; Stefan M Pulst; Tetsuo Ashizawa
Journal:  Arch Neurol       Date:  2002-08

Review 9.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Authors:  Ludger Schöls; Peter Bauer; Thorsten Schmidt; Thorsten Schulte; Olaf Riess
Journal:  Lancet Neurol       Date:  2004-05       Impact factor: 44.182

10.  Demonstration Project on Epilepsy in Brazil: situation assessment.

Authors:  Li M Li; Paula T Fernandes; Ana L A Noronha; Lucia H N Marques; Moacir A Borges; Fernando Cendes; Carlos A M Guerreiro; Dirce M T Zanetta; Hanneke M de Boer; Javier Espíndola; Claudio T Miranda; Leonid Prilipko; Josemir W Sander
Journal:  Arq Neuropsiquiatr       Date:  2007-06       Impact factor: 1.420

View more
  2 in total

Review 1.  The genetic and molecular features of the intronic pentanucleotide repeat expansion in spinocerebellar ataxia type 10.

Authors:  Tatsuaki Kurosaki; Tetsuo Ashizawa
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

Review 2.  Deciphering Neurodegenerative Diseases Using Long-Read Sequencing.

Authors:  Yun Su; Liyuan Fan; Changhe Shi; Tai Wang; Huimin Zheng; Haiyang Luo; Shuo Zhang; Zhengwei Hu; Yu Fan; Yali Dong; Jing Yang; Chengyuan Mao; Yuming Xu
Journal:  Neurology       Date:  2021-08-13       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.